Open
14.74 -2.45
24h
Min
14.76
Max
15.23
Income | 19M -41M |
---|---|
Sales | 6.9M 82M |
EPS | -0.19 |
Profit margin | -50.44 |
Employees | 385 |
EBITDA | 20M -26M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +124.72% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | -432M 1.3B |
---|---|
Previous open | 17.19 |
Previous close | 14.74 |
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 34 USD 124.72%
High 47 USD
Low 22 USD
Based on 15 Wall Street analysts offering 12 month price targets forTravere Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$